FHTX
Foghorn Therapeutics Inc
2.00$
-1.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -67.0% | -12.5% | +36.4% | +13.4% | -63.4% | +108.4% | +27.0% | +7.9% | +13.4% | -64.7% | +391.9% | – | |
| – | -96.8% | -2.0% | -4.2% | -12.5% | +8.7% | – | – | +2,122.4% | -96.0% | -70.3% | – | – | |
| – | – | +2.7% | +36.4% | +13.4% | -63.4% | +108.4% | +11.8% | -278.0% | – | -64.1% | +430.6% | – | |
| – | -11.0% | +9.3% | -6.8% | +3.7% | -16.9% | +5.5% | -3.4% | -4.3% | +14.7% | -20.4% | +1.4% | – | |
| – | -15.5% | +9.8% | -5.0% | -4.8% | -8.9% | +13.9% | -5.2% | -3.1% | +2.2% | -3.2% | -3.4% | – | |
| – | +265.6% | +9.4% | +0.8% | -5.5% | -15.2% | +7.5% | -3.8% | -76.0% | +321.5% | -12.3% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +169.1% | -60.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.